✨ AI
Curetrax
Remote Monitoring Platform for Blood Cancer Care
Role: Full-Stack Engineer
Node.jsNestJSTypeScriptReact NativePostgreSQLAWS LambdaAWS CognitoAWS TimestreamAWS ChimeRAGGarmin Connect SDKWearable Temperature SensorsFirebaseDocker
Curetrax is a Toronto-based remote monitoring platform for blood cancer care, led by Armin (25+ years of clinical and research experience in allogeneic stem-cell transplantation and cell therapy) alongside a small technical team. The product line spans CuretraxAllo for allogeneic stem-cell transplant (aHSCT) patients, CuretraxCAR19 for CAR T-cell (CD19-targeted) patients, CuretraxDoc for clinicians, and Curetrax Survey for data collection. CuretraxCAR19 — the most detailed product — provides 24/7 remote monitoring of patient vitals and activity via Garmin wearable, manual vitals reporting for fast-changing metrics, a structured clinician dashboard, medication management with automatic patient notification, neurotoxicity/cognitive screening (including on-screen handwriting assessments), daily symptom reporting, automated alerting on deviations, and multilingual support (English, French, German, Spanish). The case study cites 5k+ installations, treatment-specific monitoring, and real-time alerting as headline metrics, and the clinical approach is grounded in a published ScienceDirect paper on a patient-centered mobile application for aHSCT patients, with several Curetrax team members listed among the paper's disclosures.
What we built
Product Line & Clinical Grounding
- CuretraxAllo for allogeneic stem-cell transplant (aHSCT) patients, CuretraxCAR19 for CAR T-cell (CD19-targeted) patients, CuretraxDoc for clinicians, and Curetrax Survey for structured data collection.
- CuretraxCAR19 addresses treatment-specific challenges including Cytokine Release Syndrome (CRS), infection susceptibility, and Immune Effector Cell Associated Neurotoxicity (ICANS).
- Clinical basis published in a ScienceDirect paper on a patient-centered mobile application for aHSCT patients, with Curetrax team members listed among the paper's disclosures.
- Traction cited: 5k+ installations, treatment-specific monitoring, and real-time alerting as headline metrics.
Patient Mobile Application
- Developed a React Native mobile application for transplant and CAR T-cell patients.
- Enabled symptom reporting, medication tracking, quality-of-life assessments, and treatment-specific questionnaires.
- Built workflows for GvHD monitoring, neurological assessments, Mini-Cog evaluations, and daily health check-ins.
- Integrated wearable device synchronization and real-time health data collection.
Clinician Mobile Application (CuretraxDoc)
- Built a dedicated mobile application for physicians and care teams.
Impact
- Enabled earlier patient discharge while maintaining continuous clinical oversight.
- Reduced manual monitoring workloads through automated wearable integrations and intelligent alerting.
- Improved patient engagement and treatment adherence through mobile-first care experiences.
- Supported multi-center clinical programs and research initiatives with standardized, high-quality health data.
- Delivered a comprehensive remote monitoring ecosystem connecting patients, clinicians, hospitals, and researchers throughout the blood cancer treatment journey.
